Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Transplantation and Cellular Therapy|November 7, 2022
Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for MalignancySimone Dertschnig, Peter Gergely, Jürgen Finke, et al.
Annals of Hematology|January 14, 2009
Aplastic anemia and concomitant autoimmune diseasesMagnus P Stalder, Alicia Rovó, Jörg Halter, et al.
Annals of Hematology|October 24, 2020
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trialClaire Seydoux, Michael Medinger, Sabine Gerull, et al.
Annals of Hematology|September 19, 2020
Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantationBeatrice Drexler, Felicitas Zurbriggen, Tamara Diesch, et al.
Blood|August 1, 2007
Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantationAndré Tichelli, Christoph Bucher, Alicia Rovó, et al.
Swiss Medical Weekly|May 23, 2015
Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
Blood Advances|August 27, 2021
Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantationStéphane Buhler, Helen Baldomero, Sylvie Ferrari-Lacraz, et al.
Swiss Medical Weekly|April 4, 2019
Updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
Transplantation and Cellular Therapy|December 11, 2023
Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCTKhalil Ben Hassine, Claire Seydoux, Sonia Khier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2013
Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantationAndreas Holbro, Thomas Lehmann, Sabine Girsberger, et al.
Pageof 11